Risk factors for medication-overuse headache: an 11-year follow-up study. The Nord-Trøndelag Health Studies
- PMID: 22018971
- DOI: 10.1016/j.pain.2011.08.018
Risk factors for medication-overuse headache: an 11-year follow-up study. The Nord-Trøndelag Health Studies
Abstract
Medication-overuse headache (MOH) is relatively common, but its incidence has not been calculated and there are no prospective population-based studies that have evaluated risk factors for developing MOH. The aim of this study was to estimate incidences of and identify risk factors for developing chronic daily headache (CDH) and MOH. This longitudinal population-based cohort study used data from the Nord-Trøndelag Health Surveys performed in 1995-1997 and 2006-2008. Among the 51,383 participants at baseline, 41,766 were eligible approximately 11 years later. There were 26,197 participants (responder rate 63%), among whom 25,596 did not report CDH at baseline in 1995-1997. Of these, 201 (0.8%) had MOH and 246 (1.0%) had CDH without medication overuse (CDHwoO) 11 years later. The incidence of MOH was 0.72 per 1000 person-years (95% confidence interval 0.62-0.81). In the multivariate analyses, a 5-fold risk for developing MOH was found among individuals who at baseline reported regular use of tranquilizers [odds ratio 5.2 (3.0-9.0)] or who had a combination of chronic musculoskeletal complaints, gastrointestinal complaints, and Hospital Anxiety and Depression Scale score ≥ 11 [odds ratio 4.7 (2.4-9.0)]. Smoking and physical inactivity more than doubled the risk of MOH. In contrast, these factors did not increase the risk of CDHwoO. In this large population-based 11-year follow-up study, several risk factors for MOH did not increase the risk for CDHwoO, suggesting these are pathogenetically distinct. If the noted associations are causal, more focus on comorbid condition, physical activity, and use of tobacco and tranquilizers may limit the development of MOH.
Copyright © 2011 International Association for the Study of Pain. Published by Elsevier B.V. All rights reserved.
Comment in
-
Medication overuse headache: a silent pandemic.Pain. 2012 Jan;153(1):7-8. doi: 10.1016/j.pain.2011.10.021. Epub 2011 Nov 8. Pain. 2012. PMID: 22074994 No abstract available.
References
-
- Aamodt AH, Hagen K, Bråthen G, Zwart J-A, Stovner LJ. Headache prevalence related to smoking and alcohol use. The Head-HUNT study. Eur J Neurol. 2006;13:1233-1238.
-
- Aamodt AH, Stovner LJ, Hagen K, Zwart JA. Comorbity of headache and gastrointestinal complaints. The HUNT study. Cephalalgia. 2008;28:144-151.
-
- Aaseth K, Grande RB, Kværner KJ, Gulbrandsen P, Lundqvist C, Russell MB. Prevalence of secondary chronic headaches in a population-based sample of 30–44-year-old persons. The Akerhus Study of Chronic Headache. Cephalalgia. 2008;28:705-713.
-
- Bigal ME, Serrano D, Buse D, Scher A, Stewart WF, Lipton RB. Acute migraine medications and the evolution from episodic to chronic migraine: a longitudinal population-based study. Headache. 2008;48:1157-1168.
-
- Castillo J, Muñoz P, Guitera V, Pascual J. Epidemiology of chronic daily headache in the general population. Headache. 1999;39:190-196.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
